+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of simvastatin ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia



Effect of simvastatin ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia



Hepatology 15(6): 1072-1078



It has been recently shown that the newest hypocholesterolemic agent, simvastatin, lowers the biliary cholesterol saturation index and that its association with ursodeoxycholic acid renders it more effective. To determine the mechanism by which simvastatin decreases the biliary cholesterol saturation index, we evaluated hepatic secretion rates of cholesterol, bile acids and phospholipids, and cholic acid pool size, turnover and synthesis in eight hyperlipidemic patients (five women and three men, age range = 38 to 65 yr). These assessments were conducted before treatment, after 4 wk of simvastatin (40 mg/day), after 4 wk of ursodeoxycholic acid (600 mg/day) and after a further 4 wk of a combination therapy of simvastatin (40 mg/day) plus ursodeoxycholic acid (600 mg/day). The cholesterol saturation index was significantly reduced with simvastatin (from 1.51 .+-. 0.10 to 0.94 .+-. 0.05, mean .+-. S.E.; p < 0.02), with ursodeoxycholic acid (from 1.51 .+-. 0.10 to 0.86 .+-. 0.03, mean .+-. S.E.; p < 0.02) and with the combination of simvastatin plus ursodeoxycholic acid (from 1.51 .+-. 0.01 to 0.70 .+-. 0.05, p < 0.02). The cholesterol saturation index during combination therapy was significantly lower (p < 0.02) than that reached during the use of simvastatin and ursodeoxycholic acid. Both simvastatin and ursodeoxycholic acid significantly reduced the hepatic secretion rate of cholesterol (from 130 .+-. 14 .mu.mol/hr to 81 .+-. .mu.mol/hr, p < 0.01) without affecting bile acid and phospholipid outputs. The combination induced a significantly greater decrease of biliary cholesterol output (from 130 .+-. 14 to 53 .+-. 5 .mu.mol/hr). Cholic acid pool size, synthesis and turnover rate were not affected by simvastatin administration, but ursodeoxychloic acid and the combination therapy significantly increased (p < 0.02) the turnover of cholic acid. Our study shows that simvastatin decreases the cholesterol saturation index by reducing the biliary cholesterol secretion rate and that a synergistic effect is obtained by the addition of ursodeoxycholic acid.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007259684

Download citation: RISBibTeXText

PMID: 1592346

DOI: 10.1002/hep.1840150617


Related references

Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects. Italian Journal of Gastroenterology 27(8): 441-445, 1995

Effect of ursodeoxycholic acid administration biliary lipid secretion and cholic acid metabolic in pbc. Journal of Hepatology 7(SUPPL 1): S150, 1988

The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid. American Journal of Clinical Nutrition 43(2): 239-250, 1986

A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. Journal of Clinical Gastroenterology 26(4): 287-291, 1998

Biliary and plasma lipid composition during long-term simvastatin given alone and in combination with ursodeoxycholic acid. Hepatology 26(4 PART 2): 381A, 1997

Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology 85(6): 1248-1256, 1983

Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans. Gut 44(4): 552-556, 1999

Changes in biliary lipid secretion and cholic acid kinetics induced by diet and diet + simvastatin in obese subjects. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A927, 2000

Effect of ursodeoxycholic acid on biliary lipid secretion and bile acid metabolism in primary biliary cirrhosis. Hepatology 8(5): 1317, 1988

Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology. 17(6): 1028-1032, 1993

Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients. Digestive Diseases and Sciences 24(2): 123-128, 1979

Evidence that ursodeoxycholic acid increases biliary excretion of cholic acid and chenodeoxycholic acid in man. Gastroenterology 106(4 SUPPL ): A935, 1994

Ursodeoxycholic acid, differently from simvastatin, decreases cholesterol secretion in dieting obese subjects. Gastroenterology 106(4 SUPPL ): A941, 1994

Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 27(3): 649-655, 1998

The effects of simvastatin and ursodeoxycholic acid administration on cholesterol metabolism in hypercholesterolemic patients with primary biliary cirrhosis. Hepatology 32(4 Pt 2): 170A, 2000